TY - JOUR
T1 - Long-term Efficacy of Intranasal Mupirocin Ointment
T2 - A Prospective Cohort Study of Staphylococcus aureus Carriage
AU - Doebbeling, Bradley N.
AU - Reagan, David R.
AU - Pfaller, Michael A.
AU - Houston, Alison K.
AU - Hollis, Richard J.
AU - Wenzel, Richard P.
N1 - Funding Information:
AcceptedforpublicationOctober28,1993. Theoverall study was supported in part by grant RR59 fromtheGeneralClinicalResearchCentersProgram,Di¬ vision ofResearch Resources, National Institutes ofHealth, Bethesda, Md. The original clinical (rial was supported in partbyagrantfromSmithKlineBeechamPharmaceuti¬ cals,Conshohocken,Pa. Thisstudywaspresentedinpartatthe31stInter- scienceConferenceonAntimicrobialAgentsandChemo¬ therapy,Chicago,III,September30 and October2, 1991.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 1994/7/11
Y1 - 1994/7/11
N2 - Background: We investigated the long-term effect of a single 5-day application of intranasal mupirocin calcium ointment on Staphylococcus aureus nasal and hand colonization. The subjects were 68 healthy volunteers who were health care workers with stable S aureus nasal carriage and who had participated in a randomized, double-blind, placebo-controlled clinical trial of intranasal mupirocin ointment. Methods: A 1-year prospective cohort study of S aureus nasal carriers after treatment with active drug or placebo was performed. Cultures were obtained from all subjects 6 and 12 months after therapy. All subjects returned for the 6-month visit; 63 (93%) were examined at 1 year. The major outcome measure was the relative proportion of any S aureus cultured at either site at 6 and 12 months. The S aureus isolates were typed by restriction endonuclease analysis of plasmid DNA and by antibiotic susceptibility tests; the similarity of nasal and hand isolate "fingerprints" was compared. Results: At 6 months, nasal carriage was 48% in the treatment group vs 72% in controls (relative risk, 0.68; 95% confidence interval, 0.45 to 1.02; P=.054); at 1 year, nasal carriage was 53% vs 76%, respectively (relative risk, 0.70; 95% confidence interval, 0.48 to 1.02; P=.056). Hand carriage at 6 months was significantly reduced among mupirocin recipients relative to controls (15% and 48%; P=.04, adjusted for the baseline rate of hand carriage). Thirty-six percent of treated subjects were recolonized in the nares with a new strain at 1 year, whereas 34% had reisolation of the original strain after initially negative posttherapy cultures. During the year of follow-up, hand carriage was observed at least once in two thirds of the subjects. Nearly all of the hand isolates (87%) exactly matched the subjects’ coincident nasal plasmid fingerprint and antibiogram type. Conclusions: A single brief treatment course of intranasal mupirocin was effective in reducing nasal S aureus carriage for up to 1 year. When S aureus was recovered after nasal decolonization, the new isolate was as likely to represent colonization with a new strain as reisolation of the original strain. Staphylococcus aureus hand carriage was significantly decreased 6 months after therapy, further implicating the nares as the primary reservoir site for hand carriage.
AB - Background: We investigated the long-term effect of a single 5-day application of intranasal mupirocin calcium ointment on Staphylococcus aureus nasal and hand colonization. The subjects were 68 healthy volunteers who were health care workers with stable S aureus nasal carriage and who had participated in a randomized, double-blind, placebo-controlled clinical trial of intranasal mupirocin ointment. Methods: A 1-year prospective cohort study of S aureus nasal carriers after treatment with active drug or placebo was performed. Cultures were obtained from all subjects 6 and 12 months after therapy. All subjects returned for the 6-month visit; 63 (93%) were examined at 1 year. The major outcome measure was the relative proportion of any S aureus cultured at either site at 6 and 12 months. The S aureus isolates were typed by restriction endonuclease analysis of plasmid DNA and by antibiotic susceptibility tests; the similarity of nasal and hand isolate "fingerprints" was compared. Results: At 6 months, nasal carriage was 48% in the treatment group vs 72% in controls (relative risk, 0.68; 95% confidence interval, 0.45 to 1.02; P=.054); at 1 year, nasal carriage was 53% vs 76%, respectively (relative risk, 0.70; 95% confidence interval, 0.48 to 1.02; P=.056). Hand carriage at 6 months was significantly reduced among mupirocin recipients relative to controls (15% and 48%; P=.04, adjusted for the baseline rate of hand carriage). Thirty-six percent of treated subjects were recolonized in the nares with a new strain at 1 year, whereas 34% had reisolation of the original strain after initially negative posttherapy cultures. During the year of follow-up, hand carriage was observed at least once in two thirds of the subjects. Nearly all of the hand isolates (87%) exactly matched the subjects’ coincident nasal plasmid fingerprint and antibiogram type. Conclusions: A single brief treatment course of intranasal mupirocin was effective in reducing nasal S aureus carriage for up to 1 year. When S aureus was recovered after nasal decolonization, the new isolate was as likely to represent colonization with a new strain as reisolation of the original strain. Staphylococcus aureus hand carriage was significantly decreased 6 months after therapy, further implicating the nares as the primary reservoir site for hand carriage.
UR - http://www.scopus.com/inward/record.url?scp=0028290889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028290889&partnerID=8YFLogxK
U2 - 10.1001/archinte.1994.00420130101013
DO - 10.1001/archinte.1994.00420130101013
M3 - Article
C2 - 8018006
AN - SCOPUS:0028290889
SN - 0003-9926
VL - 154
SP - 1505
EP - 1508
JO - Archives of Internal Medicine
JF - Archives of Internal Medicine
IS - 13
ER -